Market Place
Sourcing Support
DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions
Drug Master Files, or DMFs, are confidential documents that play a crucial role in the pharmaceutica
America’s drug price hike conundrum in backdrop of 2019 Medicare Part D data
Nearly every
year, drugmakers ring in the new year with drug price increases in the US. This
year
Top drugs and pharmaceutical companies of 2019 by revenues
Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-
DMF submissions in 2019: India maintains bulk drug supply supremacy to US
At PharmaCompass, we highlighted
the significance of India in the global active pharmaceutical ingr
Top drugs by sales in 2017: Who sold the blockbuster drugs?
The year 2017 was a landmark year for pharmaceutical
industries in the US and Europe, with a sharp i
FDA announces generic drug user fees for FY18; Gilead acquires Kite for US$ 12 billion
This week, Phispers brings you the FY18 user fee schedule under GDUFA II, posted by the USFDA, with
India leads DMF submissions to the FDA during Q4 of 2016 and Q1 of 2017
A review of the Drug Master Files (DMFs) submitted to the United
States Food and Drug Administration
Chemical entities SHINE in the top 10 fastest-growing drugs of 2016
Global
pharmaceutical companies are increasingly focusing on the development of new
biologics. In fa
Does the FDA promote European manufacturers over others? The ice-bucket challenge winner!
This
week, Phispers brings you a short analysis on how FDA might be promoting
European drugmakers ov
Teva CEO steps down; FDA Warning Letters to firms in Japan, India & China
This week, Phispers highlights more bad news for Israeli drugmaker Teva, along with news on the &lsq
